"The MaP Study: Mapping the Patient Journey in MMA and PA"

CompletedOBSERVATIONAL
Enrollment

97

Participants

Timeline

Start Date

March 20, 2018

Primary Completion Date

May 29, 2021

Study Completion Date

May 29, 2021

Conditions
Methylmalonic AcidemiaPropionic Acidemia
Trial Locations (17)

10029

Icahn School of Medicine at Mount Sinai, New York

13005

Hôpital de la Timone, Marseille

15224

University of Pittsburgh, Pittsburgh

19104

Children's Hospital of Philadelphia, Philadelphia

21287

Johns Hopkins University School of Medicine, Baltimore

27705

Duke University Medical Center, Durham

30322

Emory Univeristy, Atlanta

37232

Vanderbilt University Medical Center, Nashville

48903

Hospital de Cruces, Barakaldo

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

75743

Hôpital Necker - Enfants Malades, Paris

94305

Stanford Health Services, Stanford

98105

Seattle Children's Hospital, Seattle

02115

Boston Children's Hospital, Boston

WC1N 3JH

Great Ormond Street Hospital, Bloomsbury

B4 6NH

Birmingham Children's Hospital, Birmingham

M13 9WL

Manchester University Hospitals, Manchester

All Listed Sponsors
lead

ModernaTX, Inc.

INDUSTRY

NCT03484767 - "The MaP Study: Mapping the Patient Journey in MMA and PA" | Biotech Hunter | Biotech Hunter